<?xml-stylesheet type="text/xsl" href="https://www.vetnurse.co.uk/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Vectra spot-on re-categorised as NFA-VPS</title><link>/b/veterinary-nursing-news/posts/vectra-spot-on-recategorised-as-nfa-vps</link><description> Ceva Animal Health has announced that Vectra 3D spot-on solution for dogs and Vectra Felis 423mg/42.3mg spot-on solution for cats have been recategorised from POM-V to NFA-VPS products. 
 The re-categorisation means veterinary practices can sell the</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>